IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Conditions
Relapsed/Refractory Primary Central Nervous System Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Cancer Center, Phoenix, Arizona, United States
Contact: Principal Investigator (Mazie Tsang, MD)HonorHealth Cancer Center, Scottsdale, Arizona, United States
Contact: Principal Investigator (Amir Azadi, MD)Providence Medical Foundation, Fullerton, California, United States
Contact: Principal Investigator (Jose Carrillo, MD)UC Irvine Health, Orange, California, United States
Contact: Principal Investigator (Daniela Bota, MD, PhD)Yale Cancer Center, New Haven, Connecticut, United States
Contact: Principal Investigator (Sylvia Kurz, MD)John Hopkins University, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Solmaz Sahebjam, MD)Mayo Clinic Cancer Center, Jacksonville, Florida, United States
Contact: Principal Investigator (Han Tun, MD)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Tracy Batchelor, MD)Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Ka-Wai Grace Ho, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Lakshmi Nayak, MD)Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Contact: Principal Investigator (Patrick Johnston, MD, PhD)Hackensack University Medical Center, Hackensack, New Jersey, United States
Contact: Principal Investigator (Andrew Ip, MD)Atlantic Health Overlook Medical Center, Summit, New Jersey, United States
Contact: Principal Investigator (Robert Aiken, MD)NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (J Ricardo McFaline Figueroa, MD)Columbia University Irving Medical Center, New York, New York, United States
Contact: Principal Investigator (Aya Haggiagi, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Christian Grommes, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Katherine Peters, MD, PhD)Providence Neurological Specialties West, Portland, Oregon, United States
Contact: Principal Investigator (Prakash Ambady, MD)UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Jan Drappatz, MD)Rhode Island Hospital, Providence, Rhode Island, United States
Contact: Principal Investigator (Thomas Ollila, MD)
Study leads
Clinical Team
Study Director
Deciphera Pharmaceuticals, LLC